Literature DB >> 302769

Crude transfer-factor preparations stimulate trypsinized human lymphocytes to form rosettes with sheep red cells.

H Valdimarsson, R L McGuire.   

Abstract

The binding sites for sheep red cells (E) on human lymphocytes are trypsin-sensitive but regenerate in vitro on incubation at 37 degrees C. The rate of this regeneration was increased in the presence of dialysates of human leucocyte extracts (DLE). Thus incubation of trypsinized lymphocytes for 3 hr in appropriate dilutions of DLE resulted in a 2- to 6-fold increase of E-binding activity above that observed in medium-incubated control lymphocytes. Dialysates prepared from human thymus and brain similarly accelerated recovery of E-binding activity whilst dialysates of human fibroblasts and liver cells were inactive. The regeneration of trypsinized membrane immunoglobulin was slightly delayed in the presence of DLE. These findings indicate that leucocyte dialysates contain an activity which preferentially stimulates the regeneration of a T-lymphocyte membrane component. It is suggested that this activity may account for the immunological restoration observed in some patients with T-lymphocyte deficiency after injection of leucocyte dialysates.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 302769      PMCID: PMC1541096     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes.

Authors:  N F Mendes; P J Saraiva; O B Santos
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

Review 2.  Treatment of infectious and neoplastic diseases with transfer factor.

Authors:  C H Kirkpatrick; J I Gallin
Journal:  Oncology       Date:  1974       Impact factor: 2.935

Review 3.  Thymic hormones and the immune response.

Authors:  N Trainin
Journal:  Physiol Rev       Date:  1974-04       Impact factor: 37.312

4.  Restoration of T-lymphocyte deficiency with dialysable leucocyte extract.

Authors:  H Valdimarsson; G Hambleton; K Henry; I McConnell
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

5.  Rosette-forming cells, immunologic deficiency diseases and transfer factor.

Authors:  J Wybran; A S Levin; L E Spitler; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

Review 6.  Transfer factor in cellular immunity.

Authors:  H S Lawrence
Journal:  Harvey Lect       Date:  1974

Review 7.  Transfer factor.

Authors:  H S Lawrence
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

Review 8.  Uses of transfer factor.

Authors:  A Basten; S Croft; D F Kenny; D S Nelson
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

9.  Letter: Specificity of transfer factor.

Authors:  M R Salaman; H Valdimarsson
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

10.  Thymosin activity in patients with cellular immunodeficiency.

Authors:  D W Wara; A L Goldstein; N E Doyle; A J Ammann
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

  10 in total
  2 in total

1.  Dual action of leucocyte dialysates and of thymosin on the recovery of sheep-cell-rosetting capacity in trypsinized human lymphocytes.

Authors:  I L Sargent; M R Salaman; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

2.  [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)].

Authors:  C P Sodomann; G Maerker-Alzer; K Havemann; C Dienst; H Schultz; D Mitrenga; K Schumacher; G A Martini
Journal:  Klin Wochenschr       Date:  1979-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.